What Is Osteoarthritis?
Osteoarthritis (OA) is the most prevalent musculoskeletal condition globally, affecting over 500 million people and representing the leading cause of pain-related disability in older adults. It has long been characterised as a "wear and tear" disease — a simple mechanical attrition of articular cartilage from decades of loading. This framing, while intuitively appealing, is incomplete and clinically unhelpful. Contemporary understanding recognises OA as a whole-joint disease involving cartilage, subchondral bone, synovium, ligaments, periarticular muscles, and the joint capsule, driven by a complex interaction of mechanical, metabolic, and biological factors. Synovial inflammation — once thought absent from OA — is now recognised as present and clinically significant in the majority of OA joints, contributing substantially to pain and disease progression. This reframing matters because it opens therapeutic pathways that the wear-and-tear model forecloses.
The Biology of OA
Articular cartilage is avascular, aneural, and has limited intrinsic repair capacity. Under normal conditions, chondrocytes (cartilage cells) maintain a dynamic equilibrium between matrix synthesis and degradation. In OA, this balance is disrupted: mechanical overloading, inflammatory cytokines (IL-1β, TNF-α), and metabolic factors shift chondrocytes toward a catabolic state, producing matrix-degrading enzymes (matrix metalloproteinases and aggrecanases) that progressively break down the collagen and proteoglycan framework of the cartilage. Subchondral bone remodels in response, producing the sclerosis and osteophyte formation visible on radiographs. The synovium responds to cartilage breakdown products by mounting an inflammatory response — producing further cytokines that perpetuate the cycle. Pain in OA arises from the subchondral bone (which, unlike cartilage, is innervated), the synovium, periarticular ligaments, and crucially from central sensitisation — explaining why OA pain often bears a poor relationship to structural severity on imaging.
The Imaging Disconnect
One of the most important clinical concepts in OA management is the weak correlation between imaging findings and symptoms. Population studies consistently demonstrate that radiological OA — joint space narrowing, osteophytes, subchondral sclerosis — is present in approximately 40% of people over 70 who have no knee pain whatsoever. Conversely, significant pain can exist with mild radiological changes. This disconnect is explained by the central sensitisation component of OA pain, individual variation in nociceptor sensitivity, psychosocial factors, and muscle-mediated joint loading. Communicating this clearly to patients is therapeutically powerful: a radiograph showing "bone on bone" does not predict pain, function, or the response to treatment, and does not mandate surgery.
Exercise is the best medicine: Multiple systematic reviews and meta-analyses confirm that exercise — both aerobic and resistance training — reduces pain and improves function in knee and hip OA at least as effectively as NSAIDs, with none of the gastrointestinal, cardiovascular, or renal side effects. Exercise does not accelerate joint degeneration. Exercise loads cartilage, which requires cyclical compression to receive nutrition (it has no direct blood supply). Inactivity starves cartilage and accelerates its deterioration.
Evidence-Based Management
Clinical guidelines from OARSI, NICE, and the Royal Australian College of General Practitioners converge on a core recommendation: exercise and weight management are first-line treatments for OA, and should be initiated before considering pharmacological or surgical options. Resistance training — particularly targeting the quadriceps, hip abductors, and hip extensors — reduces joint loading by improving muscular shock absorption and joint centring. Aerobic exercise reduces systemic inflammation and improves overall function. Manual therapy — mobilisation of the affected joint and adjacent segments — provides meaningful short-term pain relief and improves range of motion, enhancing the quality of exercise rehabilitation. Hydrotherapy is valuable for patients whose land-based exercise is limited by pain or comorbidities. Total joint replacement surgery produces excellent outcomes for end-stage OA, but outcomes are substantially better when patients enter surgery with higher baseline fitness and muscle strength — making prehabilitation an important component of the surgical pathway.
Living Well with Osteoarthritis
OA is a manageable condition — not an inevitable sentence of progressive disability. The strongest predictors of poor outcome are physical inactivity, obesity, catastrophising pain beliefs, and social isolation. All four are modifiable. Patients who understand the biology of their condition, who engage in progressive exercise, manage weight, optimise sleep and diet, and maintain social engagement have markedly better pain and function outcomes. The goal of management is not to restore a joint to a pre-arthritic state — it is to optimise the person's capacity to live fully within the joint they have.
References & Further Reading
- Kolasinski SL, et al. ACR/AF guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–233.
- Loeser RF, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–1707.
- Fransen M, et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015;1:CD004376.